Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FY7ZG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,644
Award facts
- Contract value 100% obligated
- $4,644.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On July 17, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,644.48 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by July 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. The company's role within the DLA supply chain supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. BIKTARVY, an HIV antiretroviral medication, represents one of the specialized pharmaceutical products delivered through the company's extensive federal contract portfolio, demonstrating AmerisourceBergen's capability to fulfill critical medical supply requirements across the federal healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FY7ZG?
SPE2DB25FY7ZG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2025.
How much is contract SPE2DB25FY7ZG worth?
The government has obligated $4,644 on SPE2DB25FY7ZG.
Is contract SPE2DB25FY7ZG an order under another contract?
Yes. SPE2DB25FY7ZG is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY7ZG competed?
The extent of competition for SPE2DB25FY7ZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award